Xiujuan Qu

7PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 30, 2026
Optimal, Interpretable, and Personalized Immune Checkpoint Inhibitor Duration in Non-Small Cell Lung Cancer: A Multicenter Real-World Study.

|Jun 05, 2026
HMGCS1 drives cholesterol-dependent membrane repair and shields tumor cells from lymphocyte attack.

|Jun 01, 2026
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.

|Aug 13, 2025
Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial.

Xiang'an Wu, Dongmei Quan, Wei Li

|Jan 09, 2025
ANXA10 sensitizes microsatellite instability-high colorectal cancer to anti-PD-1 immunotherapy via assembly of HLA-DR dimers by regulating CD74.

Yiting Sun, Bowen Yang, Ti Wen

|Jan 03, 2024
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept.

Wenyu Luo, Ti Wen, Xiujuan Qu

Pageof 2

Frequent Collaborators

1 joint publications

Xiang'an Wu

1 joint publications

Dongmei Quan

1 joint publications

Karin Wisskirchen

1 joint publications

Wei Wu